MAGY Only Makes Sense If You Already Own The Underlying
seekingalpha.com
Want to monitor RAIN?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor RAINRain Therapeutics Inc. is a clinical-stage precision oncology company developing therapies that target oncogenic drivers for which it is able to genetically select patients it believes will most likely benefit. This approach includes using a tumor-agnostic strategy to select patients based on their tumors’ underlying genetics rather than histology.